Below are the most recent publications written about "Enoxaparin" by people in Profiles.
-
Holubar SD, Eisenstein S, Bordeianou LG, Chapman WC, Crowell KT, Davids JS, Hrabe JE, Justiniano CF, Kapadia MR, Kin CJ, Krane MK, Lee EC, Olortegui KS, Poylin V, Saraidaridis JT, Scow JS, Plietz MC. Venous Thromboembolism Prophylaxis Practice Patterns, Outcomes, and Risk Stratification After Surgery for IBD: A National Surgical Quality Improvement Program IBD Collaborative Study. Dis Colon Rectum. 2025 09 01; 68(9):1062-1073.
-
Hayden JP, Nelson J, Frankenberger E, Vanni AJ. Risk of Hematuria-related Complications Associated With Anticoagulant and Antiplatelet Medications: A Single-Institution Retrospective Cohort Study. Urology. 2025 03; 197:12-17.
-
Bigos R, Solomon E, Dorfman JD, Ha M. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients. J Surg Res. 2021 09; 265:122-130.
-
Subedi P, Syed MP, Shah T, Siddiqui AD. Spontaneous large anterior chest wall haematoma causing haemorrhagic shock during enoxaparin therapy. BMJ Case Rep. 2020 Jun 02; 13(6).
-
Wang X, Mathew C, Korapati S, Bathini VG. Successful Long-term Anticoagulation with Enoxaparin in a Patient with a Mechanical Heart Valve. Pharmacotherapy. 2020 02; 40(2):174-177.
-
Chi G, Gibson CM, Kalayci A, Cohen AT, Hernandez AF, Hull RD, Kahe F, Jafarizade M, Sharfaei S, Liu Y, Harrington RA, Goldhaber SZ. Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy. Intensive Care Med. 2019 04; 45(4):477-487.
-
Nafee T, Gibson CM, Yee MK, Alkhalfan F, Chi G, Travis R, Mir M, Kalayci A, Jafarizade M, Ganti A, Kazmi SH, Ghaffarpasand E, Pitliya A, Datta S, Sharfaei S, Alihashemi M, Elsaiey A, Qamar I, Jahansouz M, Talib U, Kahe F, Habibi S, Abdelwahed M, Tariq F, Kaur M, Younes A, Walia SS, Singh A, Dildar SM, Afzal MK, Kerneis M. Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism. Expert Rev Cardiovasc Ther. 2018 Nov; 16(11):845-855.
-
Schomburg J, Krishna S, Soubra A, Cotter K, Fan Y, Brown G, Konety B. Extended outpatient chemoprophylaxis reduces venous thromboembolism after radical cystectomy. Urol Oncol. 2018 02; 36(2):77.e9-77.e13.
-
Stensland KD, Katz EG, Canes D. Re: Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin: J. J. Pariser, S. M. Pearce, B. B. Anderson, V. T. Packiam, V. N. Prachand, N. D. Smith and G. D. Steinberg J Urol 2017;197:302-307. J Urol. 2017 09; 198(3):707-708.
-
Lui JK, McIntosh LJ, Escobar Valle J, Stockl T, Summers S. Facial Drooping, Aphasia, and an Incidental Lung Mass in a Nonsmoker. J Intensive Care Med. 2017 Mar; 32(3):228-230.